title: Uveal metastasis and myasthenia gravis in a patient with recurrent renal cell carcinoma treated with pazopanib.
authors.affiliation: Department of Medical Oncology, Auckland City Hospital, Auckland, New Zealand. Electronic address: abbeyjebb@hotmail.com.
authors.forename: Abbey
authors.initials: A
authors.lastname: Jebb
authors.affiliation: Department of Ophthalmology, Auckland City Hospital, Auckland, New Zealand.
authors.forename: Peter
authors.initials: P
authors.lastname: Hadden
authors.affiliation: Department of Medical Oncology, Auckland City Hospital, Auckland, New Zealand.
authors.forename: Reuben J
authors.initials: RJ
authors.lastname: Broom
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000556:secondary*; D006801:Humans; D007191:Indazoles; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D009157:Myasthenia Gravis / Q000473:pathology*; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000188:drug therapy; D011379:Prognosis; D011743:Pyrimidines / Q000627:therapeutic use*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors; D013449:Sulfonamides / Q000627:therapeutic use*; D014604:Uveal Neoplasms / Q000188:drug therapy / Q000556:secondary*
chemical_list: D020533:Angiogenesis Inhibitors; D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib; D040262:Receptors, Vascular Endothelial Growth Factor
keywords: Paraneoplastic; tyrosine kinase inhibitor